Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Isabel Gerber is active.

Publication


Featured researches published by Isabel Gerber.


Scientific Reports | 2016

Synergistic interactions of blood-borne immune cells, fibroblasts and extracellular matrix drive repair in an in vitro peri-implant wound healing model.

Melanie A. Burkhardt; Jasmin Waser; Vincent Milleret; Isabel Gerber; Maximilian Y. Emmert; Jasper Foolen; Simon P. Hoerstrup; Falko Schlottig; Viola Vogel

Low correlations of cell culture data with clinical outcomes pose major medical challenges with costly consequences. While the majority of biomaterials are tested using in vitro cell monocultures, the importance of synergistic interactions between different cell types on paracrine signalling has recently been highlighted. In this proof-of-concept study, we asked whether the first contact of surfaces with whole human blood could steer the tissue healing response. This hypothesis was tested using alkali-treatment of rough titanium (Ti) surfaces since they have clinically been shown to improve early implant integration and stability, yet blood-free in vitro cell cultures poorly correlated with in vivo tissue healing. We show that alkali-treatment, compared to native Ti surfaces, increased blood clot thickness, including platelet adhesion. Strikingly, blood clots with entrapped blood cells in synergistic interactions with fibroblasts, but not fibroblasts alone, upregulated the secretion of major factors associated with fast healing. This includes matrix metalloproteinases (MMPs) to break down extracellular matrix and the growth factor VEGF, known for its angiogenic potential. Consequently, in vitro test platforms, which consider whole blood-implant interactions, might be superior in predicting wound healing in response to biomaterial properties.


Biomaterials | 2015

The ultrastructure of fibronectin fibers pulled from a protein monolayer at the air-liquid interface and the mechanism of the sheet-to-fiber transition

Maria Mitsi; Stephan Handschin; Isabel Gerber; Ruth Schwartlander; Enrico Klotzsch; Roger Wepf; Viola Vogel

Fibronectin is a globular protein that circulates in the blood and undergoes fibrillogenesis if stretched or under other partially denaturing conditions, even in the absence of cells. Stretch assays made by pulling fibers from droplets of solutions containing high concentrations of fibronectin have previously been introduced in mechanobiology, particularly to ask how bacteria and cells exploit the stretching of fibronectin fibers within extracellular matrix to mechano-regulate its chemical display. Our electron microscopy analysis of their ultrastructure now reveals that the manually pulled fibronectin fibers are composed of densely packed lamellar spirals, whose interlamellar distances are dictated by ion-tunable electrostatic interactions. Our findings suggest that fibrillogenesis proceeds via an irreversible sheet-to-fiber transition as the fibronectin sheet formed at the air-liquid interface of the droplet is pulled off by a sharp tip. This far from equilibrium process is driven by the externally applied force, interfacial surface tension, shear-induced fibronectin self-association, and capillary force-induced buffer drainage. The ultrastructural characterization is then contrasted with previous FRET studies that characterized the molecular strain within these manually pulled fibers. Particularly relevant for stretch-dependent binding studies is the finding that the interior fiber surfaces are accessible to nanoparticles smaller than 10 nm. In summary, our study discovers the underpinning mechanism by which highly hierarchically structured fibers can be generated with unique mechanical and mechano-chemical properties, a concept that might be extended to other bio- or biomimetic polymers.


Acta Biomaterialia | 2010

On the in vitro and in vivo degradation performance and biological response of new biodegradable Mg–Y–Zn alloys

Anja C. Hänzi; Isabel Gerber; Michael Schinhammer; Jörg F. Löffler; Peter J. Uggowitzer


Intermetallics | 2006

Cytotoxicity of Zr-based bulk metallic glasses

Stefano Buzzi; Kaifeng Jin; Peter J. Uggowitzer; Samuele Tosatti; Isabel Gerber; Jörg F. Löffler


Archive | 2004

Methods of treating bone or cartilage conditions by the administration of creatine

Theo Wallimann; Isabel Gerber


Materials Science and Engineering: C | 2013

On the cytocompatibility of biodegradable Fe-based alloys

Michael Schinhammer; Isabel Gerber; Anja C. Hänzi; Peter J. Uggowitzer


Archive | 1998

Use of creatine compounds for treatment of bone or cartilage cells and tissues

Theo Wallimann; Isabel Gerber


Biomaterials Science | 2017

Clot-entrapped blood cells in synergy with human mesenchymal stem cells create a pro-angiogenic healing response

Melanie A. Burkhardt; Isabel Gerber; Cameron Moshfegh; Miriam S. Lucas; Jasmin Waser; Maximilian Y. Emmert; Simon P. Hoerstrup; Falko Schlottig; Viola Vogel


Bone | 2008

Creatine supplementation stimulates collagen type I and osteoprotegerin secretion of healthy and osoteopenic primary human osteoblast-like cells in vitro

Isabel Gerber; Hanswerner Gerber; Claudio Dora; Daniel Uebelhart; Theo Wallimann


Archive | 1998

Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben

Isabel Gerber; Theo Wallimann

Collaboration


Dive into the Isabel Gerber's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge